Crossmark

Pharmacologic management of patients with hepatic and pancreatic diseases that involve immunosuppressive therapies. Positioning within the framework of the SARS-CoV-2 (COVID-19) pandemic

Crossref DOI link: https://doi.org/10.1016/j.rgmxen.2020.06.002

Published Print: 2020-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Miranda-Zazueta, G.

González-Regueiro, J.A.

García-Juárez, I.

Moctezuma-Velázquez, C.

López-Díaz, F.J.

Pérez-González, B.

Uscanga-Domínguez, L.F.

Peláez-Luna, M.
License Information

Text and Data Mining valid from 2020-07-01

Version of Record valid from 2020-07-10
More Information

This article is maintained by: Elsevier

Article Title: Pharmacologic management of patients with hepatic and pancreatic diseases that involve immunosuppressive therapies. Positioning within the framework of the SARS-CoV-2 (COVID-19) pandemic

Journal Title: Revista de Gastroenterología de México (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rgmxen.2020.06.002

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.rgmx.2020.06.001

Content Type: article

Copyright: © 2020 Asociación Mexicana de Gastroenterología. Published by Masson Doyma México S.A.

Document is current

Any future updates will be listed below